Explore our 🎯 Q1 2026 Psychedelic Pipeline Bullseye Charts.

Analysis

Q1’25 Psychedelic Drug Development Pipeline: Bullseye Chart

This Resource is Outdated

For the latest version of this resource, please visit the Q3’25 Psychedelic Drug Development Pipeline Bullseye Charts.

Q1’25 BULLSEYE CHART

The Psychedelic Drug Development Pipeline

We map our Q1’25 Psychedelics Drug Development Tracker data onto a ‘bullseye chart’ format. Given the number of candidates included, we recommend downloading a PDF of the tracker for a better viewing experience. More information below the image.

Join Today

Independent data-driven reporting, analysis and commentary on the psychedelics space: from business and drug development through to policy reform and research.

Monthly $20 Annually $200

Subscribe to our
free newsletter


By signing up, you agree to our privacy policy. You can unsubscribe at any time.

Learn More About

Group, team &
corporate plans


Aside from group pricing, we also offer bespoke reports and regular briefings. Get in touch to discuss.